首页> 外国专利> Intermediates of Ipanema encounter the inhibitor has a pyrrole structure

Intermediates of Ipanema encounter the inhibitor has a pyrrole structure

机译:伊帕内玛中间体遇到抑制剂具有吡咯结构

摘要

PURPOSE: FTASE inhibitor intermediate having pyrrol structure intermediate is provided which has a good anticancer property. CONSTITUTION: FTase inhibitor intermediate is added in the obtained solution, and reacted at room temperature for 5 hours to give the compounds of formula 1, wherein A and D are H, phenyl or lower alkyl; B is phenyl or naphthyl; E is one of under the formulas; R1 and R2 are independently H or lower alkyl; Y is O, C=O, S=O or SO2. Thus, 234 mg of 3-hydroxycarbonyl-4-(naphthalen-1-yl)-1H-pyrrol is dissolved in 2 ml of dimethyl formamide, followed by addition of 230 mg of EDC, 101 mg of triethyl amine and 162 mg of HOBT, and stirred at 0C for 5 minutes. 124 Mg of N-(2-method ethyl)-N-methyl amine hydrochloride.
机译:目的:提供具有吡咯结构中间体的FTASE抑制剂中间体,该中间体具有良好的抗癌性能。组成:将FTase抑制剂中间体加入所得溶液中,在室温下反应5小时,得到式1化合物,其中A和D为H,苯基或低级烷基; B是苯基或萘基; E是下式之一: R1和R2独立地为H或低级烷基; Y为O,C = O,S = O或SO 2。因此,将234mg的3-羟基羰基-4-(萘-1-基)-1H-吡咯溶解在2ml的二甲基甲酰胺中,然后添加230mg的EDC,101mg的三乙胺和162mg的HOBT。 ,在0℃下搅拌5分钟。 124 Mg N-(2-方法乙基)-N-甲基胺盐酸盐。

著录项

  • 公开/公告号KR100388783B1

    专利类型

  • 公开/公告日2003-10-04

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR19980043815

  • 申请日1998-10-20

  • 分类号C07D417/12;

  • 国家 KR

  • 入库时间 2022-08-21 23:45:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号